Study: Bullied Kids More Likely to Be Obese, Develop Health Problems
Bullying may keep overweight children on the sidelines, making it more difficult for them to shed pounds.
Prolonged TV Viewing Linked to Higher Risk of Type 2 Diabetes, Heart Disease
According to a new study, prolonged TV viewing was associated with increased risk of type 2 diabetes, cardiovascular disease, and premature death.
Artificial Pancreas to Undergo Final Tests, Could Lead to FDA Approval
University of Virginia project turns a smartphone into an artificial pancreas, could transform lives of people with type-1 diabetes and replace need for testing...
Chronically Ill Children Are 88 Percent More Likely to Suffer Physical Abuse
Children with chronic health conditions such as diabetes are 88% more likely to suffer physical abuse than healthy children, according to research in the March issue of Acta Paediatrica.
T Cell Discovery Shows Promise for Type 1 Diabetes Treatment
A research team has identified the role of a type of T cell in type 1 diabetes that may lead to new treatment options for young patients.
Type 1 Diabetes Breakthrough with Artemisinin Treatment
Researchers have announced that FDA-approved artemisinins, used for decades to treat malaria, offer a completely new therapy for type 1 diabetes. It promises to be...
New Study of Human Pancreases Links Virus to Cause of Type 1 Diabetes
A team of researchers has found that a common family of viruses may play an important role in triggering the development of diabetes, particularly in children.
Study: Insulin levels in African American Children Worsen Through Puberty
Insulin levels in African American children worsen as they progress through puberty while those same levels don't change in their Caucasian counterparts, says new University of Alberta research that shows puberty is a key developmental period affecting diabetes risk.
Type 1 Diabetes Drug Very Effective in Trial
An experimental drug designed to block the advance of type 1 diabetes in its earliest stages has proven strikingly effective over two years in about half of the patients who participated in the phase 2 clinical trial.
